Dr. Bernhard Baumgartner studied genetics and molecular biology in Salzburg and Göttingen, conducted metabolic research in Barcelona, and later headed a research group at the University of Göttingen. There, he developed new methods for measuring gene activity and taught in the PhD program of the Max Planck Society.

Today, he specializes in the design and conduct of clinical studies, with a focus on new cancer drugs as well as therapies for allergies and sleep disorders.